Acting FDA Commissioner Dr. Ned Sharpless said the approval was an outgrowth of efforts to speed development of new therapies for complex diseases.
from WebMD Health https://ift.tt/2oSOXiN
via IFTTT
Acting FDA Commissioner Dr. Ned Sharpless said the approval was an outgrowth of efforts to speed development of new therapies for complex diseases.
Comments
Post a Comment